lipella.com - LIPO Company profit before taxes, interest and amortization
Quarterly EBITDA helps assess the success of local bladder drug delivery aimed at reducing toxicity. However, the lack of profitable products forces the business to rely on equity issuance, as shapes the current metric. The strategy of Lipella Pharmaceuticals (LIPO) is based on repurposing drugs for the therapy of cancer and hemorrhagic cystitis, which is reflected in the operating profit trend.
Summary analytical data breakdowns for Lipella Pharmaceuticals, Inc. (LIPO)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Lipella Pharmaceuticals|LIPO - Long-Term Debt to Equity|Short-Term Debt to Equity Lipella Pharmaceuticals Inc|LIPO - Company Aggregate Debts|Debts to Net Assets Lipella Pharmaceuticals|LIPO - Company Long-Term Debt|Current Liabilities Lipella Pharmaceuticals|Immediate Liquidity lipella.com
- earnings and market ratios statistics:
LIPO - Company Net Income|Expected Profit Lipella Pharmaceuticals|LIPO - Price to Earnings Ratio|Future Price to Earnings lipella.com|LIPO - PEG Multiple|EV/EBITDA Multiple Lipella Pharmaceuticals|LIPO - Operating profit before deduction of amortization|Earnings per share for the trailing year Lipella Pharmaceuticals|LIPO - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months lipella.com|LIPO - Earnings growth in current year|Expected earnings per share trend next year Lipella Pharmaceuticals
Summary company analytics:LIPO Lipella Pharma
Absolute operating profit measures the actual cash flow from core operations, stripped of depreciation and taxes to assess fundamental solvency. By analyzing the calculated EBITDA of Lipella Pharmaceuticals (LIPO), an investor determines the efficiency of managing clinical research outsourcing costs, where diversifying the CRO pool minimizes regulatory risks and stabilizes the financial results of Lipella Pharmaceuticals.
Competitors of Lipella Pharmaceuticals (LIPO)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|ANI Pharmaceuticals Inc - Profit before payment of interest, taxes and amortization|MannKind Corp. - Operating profit EBITDA|Operating income before deduction of amortization Amphastar Corp AMPH|Pacira BioSciences (PCRX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization SPRY (ars-pharma.com)|TBPH (Theravance Biopharma, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Aquestive Therapeutics Inc AQST|Profit before payment of interest, taxes and amortization scPharmaceuticals Inc. (SCPH)|Profit before payment of interest, taxes and amortization TECX (tectonictx.com)|Profit before payment of interest, taxes and amortization Tonix Pharmaceuticals TNXP|SXT Pharmaceuticals - Profit before payment of interest, taxes and amortization|Eupraxia Pharma - Operating profit EBITDA|BHST - Operating profit EBITDA|EXOZ (Invizyne Technologies, Inc.) - Operating profit before deduction of amortization|Oramed Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Entera Bio Ltd|ipatherapeutics.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA QNTM (Quantum BioPharma Limited)|Operating profit EBITDA FibroGen Corporation FGEN|TELO - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RANI (Rani Therapeutics)|synergychc.com (SNYR) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Rallybio|LEXX (Lexaria Bioscience Corp) - Operating profit EBITDA|Operating profit EBITDA Pulmatrix Corporation|Operating profit EBITDA PTHL|Operating profit before deduction of amortization aptorumgroup.com APM|Operating profit EBITDA LYRA (Lyra Therapeutics)|Impact BioMedical, Inc. (IBO) - Profit before interest, taxes and amortization|TNFA: Operating profit before deduction of amortization|YCBD - Operating profit EBITDA|PRFX (PainReform Ltd.) - Operating profit before deduction of amortization|CYTO: Company profit before taxes, interest and amortization|OPTN (OptiNose) - Operating profit EBITDA|Pieris Pharmaceuticals Inc (PIRS) - Operating income before deduction of amortization|Operating profit EBITDA PROC|Operating profit before deduction of amortization Petros Pharma PTPI|Operating profit EBITDA QLI (Qilian International)|Operating profit EBITDA acelyrin.com SLRN|TFFP - Profit before payment of interest, taxes and amortization
